How can ordinary bruising after filler be distinguished from suspected vascular occlusion?

Needle-related bruising usually evolves as localized discoloration and tenderness, while disproportionate pain, pallor, reticulated discoloration, cool skin or delayed capillary refill may raise concern for vascular compromise. A remote photograph cannot make a definitive distinction.

This translation has no recorded clinical or medical-language review.

Direct answer

Worsening pain and rapidly changing colour should not be left under an assumption of routine bruising.
Capillary refill is not a perfect standalone test; lighting, pressure and skin tone affect interpretation.
A new visual symptom requires urgent assessment even without obvious skin findings.

Follow the timeline

Traumatic bruising may change colour and spread near the injection or with gravity. Vascular symptoms can begin during or after treatment and progress dynamically. Serially record onset, pain intensity, colour, temperature, sensation and distribution. One calm photograph cannot show earlier deterioration or measure tissue perfusion.

Examination uses several findings

Assess skin colour, reticulation, capillary refill, temperature, tenderness, pulses where relevant, sensation and movement together. Pallor or erythema may be subtler in darker skin. Ultrasound may assist in an equipped center, but arranging it should not delay urgent care and a normal image should not automatically dismiss clinical concern.

An emergency contact plan

Before injection, the patient should know which number to use and where to go if no response is available. Increasing pain, cold skin, blistering, a net-like change, visual disturbance, eye pain or neurological symptoms should not wait for routine photo review. Record product and lot, area, volume, time and findings, and begin assessment promptly.

Scope of this article

This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.

Sources and evidence limits

These links are editorial starting points used to examine the article's boundaries.

Dermal Fillers (Soft Tissue Fillers)
U.S. Food and Drug Administration (FDA) · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Guideline for the Management of Hyaluronic Acid Filler-Induced Vascular Occlusion
Gillian Murray, Cormac Convery, Lee Walker, Emma Davies; Complications in Medical Aesthetics Collaborative (CMAC) · 2021
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Safety and Potential Complications of Facial Wrinkle Correction with Dermal Fillers: A Systematic Literature Review
Audra Janovskiene, Deividas Chomicius, Dominykas Afanasjevas, Zygimantas Petronis, Dainius Razukevicius, Egle Jagelaviciene · 2024
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Adverse Events Associated with Hyaluronic Acid Filler Injection: A Systematic Review of High-Level Evidence Studies
I. Kyriazidis et al. · 2024
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
The Use of Ultrasound Imaging in Aesthetic Injectables: A Modified Delphi Consensus
International expert Delphi panel · 2025
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review